Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Tokyo Tanabe moves new oxytocin antagonist to clinic

Dec. 12, 1997

FDA approves SERM for preventing postmenopausal osteoporosis

Dec. 11, 1997

Potential new male contraceptive under development in China

Dec. 11, 1997

Sparta acquires rights to PZG

Dec. 10, 1997

TH-9507 proceeds to toxicological studies

Dec. 10, 1997

BioTime reports preliminary phase III data from Hextend trial

Dec. 9, 1997

Lilly discovers highly potent and selective NPY Y1 receptor antagonists

Dec. 9, 1997

NPS and SmithKline Beecham sign additional extension of osteoporosis agreement

Dec. 9, 1997

HMR begins phase II trial with GA-EPO

Dec. 8, 1997

Sanofi in-licenses antidiabetic drug from Bayer

Dec. 4, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...